What type of study is this?

This is a Human Clinical Trial study.

December 8, 2025Blood

Clinical use of genome-wide hi-c sequencing for assessment of structural variants in diffuse large B-cell lymphoma

View Full Paper

Ask AI

Bookmark

Authors

Case analysis reveals copy number variants in diffuse large B-cell lymphoma, suggesting therapy refinement opportunities.

Copy number variant analysis was crucial in identifying genomic alterations underlying the aggressive DLBCL phenotype.
Further assessment yielded a significant tandem amplification on chromosome 17 associated with key gene copy increases.
Whole-genome Hi-C sequencing was applied to fresh FFPE samples, enhancing the resolution of genomic analyses.
Potential novel biomarkers could significantly influence therapy decisions in DLBCL management.

Anthony D. Schmitt (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Case analysis reveals copy number variants in diffuse large B-cell lymphoma, suggesting therapy refinement opportunities.

Copy number variant analysis was crucial in identifying genomic alterations underlying the aggressive DLBCL phenotype.
Further assessment yielded a significant tandem amplification on chromosome 17 associated with key gene copy increases.
Whole-genome Hi-C sequencing was applied to fresh FFPE samples, enhancing the resolution of genomic analyses.
Potential novel biomarkers could significantly influence therapy decisions in DLBCL management.

Anthony D. Schmitt (2025) studied this question.

View Full Paper

Ask AI

Bookmark